{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T18:58:12Z","timestamp":1790449092397,"version":"4.1.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T00:00:00Z","timestamp":1781136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T00:00:00Z","timestamp":1781136000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Jpn J Ophthalmol"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s10384-026-01368-7","type":"journal-article","created":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T06:51:05Z","timestamp":1781160665000},"page":"1190-1200","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["2024 survey of the frequency of fixed-combination eye drop use by patients with glaucoma at multiple private practices in Japan"],"prefix":"10.1007","volume":"70","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8181-0221","authenticated-orcid":false,"given":"Kenji","family":"Inoue","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minako","family":"Shiokawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiho","family":"Kunimatsu-Sanuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Goji","family":"Tomita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoko","family":"Ishida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,11]]},"reference":[{"key":"1368_CR1","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s10384-022-00970-9","volume":"67","author":"Y Kiuchi","year":"2023","unstructured":"Kiuchi Y, Inoue T, Shoji N, Nakamura M, Tanito M, Glaucoma guideline preparation committee, Japan Glaucoma Society. The Japan Glaucoma Society guidelines for glaucoma 5th edition. Jpn J Ophthalmol. 2023;67:189\u2013254.","journal-title":"Jpn J Ophthalmol"},{"key":"1368_CR2","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1097\/IJG.0b013e3181815421","volume":"18","author":"F Djafari","year":"2009","unstructured":"Djafari F, Lesk MR, Harasymowycz PJ, Desjardins D, Lachaine J. Determinants of adherence to glaucoma medical therapy in a long-term patient population. J Glaucoma. 2009;18:238\u201343.","journal-title":"J Glaucoma"},{"key":"1368_CR3","doi-asserted-by":"publisher","first-page":"557","DOI":"10.2147\/OPTH.S345944","volume":"16","author":"K Inoue","year":"2022","unstructured":"Inoue K, Komori R, Kunimatsu-Sanuki S, Ishida K, Tomita G. Frequency of use of fixed-combination eye drops by patients with glaucoma at multiple private practices in Japan. Clin Ophthalmol. 2022;16:557\u201365.","journal-title":"Clin Ophthalmol"},{"key":"1368_CR4","first-page":"1743","volume":"71","author":"K Inoue","year":"2017","unstructured":"Inoue K, Nagai M, Arai Y, Shiokawa M, Ishida K, Tomita G. Current status of therapy for glaucoma at multiple ophthalmic institutions in 2016\u2013 fixed combination eye drops. Rinsho Ganka. 2017;71:1743\u201354 (in Japanese).","journal-title":"Rinsho Ganka"},{"key":"1368_CR5","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1007\/s10384-024-01088-w","volume":"68","author":"Y Maruyama","year":"2024","unstructured":"Maruyama Y, Ikeda Y, Yoshii K, Mori K, Ueno M, Kinoshita S, et al. Improvement of corneal epithelial damage after switching from the concomitant use of brinzolamide and brimonidine to a brinzolamide\/brimonidine fixed-dose combination. Jpn J Ophthalmol. 2024;68:556\u201361.","journal-title":"Jpn J Ophthalmol"},{"key":"1368_CR6","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1007\/s10384-023-01022-6","volume":"67","author":"R Sakata","year":"2023","unstructured":"Sakata R, Mizoue S, Yoshikawa K, Adachi M, Ohkubo S, Hamada N, et al. Additive effects of brimonidine tartrate 0.1%\/brinzolamide 1% fixed-dose combination in prostaglandin analog-treated Japanese glaucoma patients. Jpn J Ophthalmol. 2023;67:668\u201377.","journal-title":"Jpn J Ophthalmol"},{"key":"1368_CR7","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s10384-024-01159-y","volume":"69","author":"H Suzuki","year":"2025","unstructured":"Suzuki H, Sakata R, Yamae T, Ishiyama Y, Sugimoto K, Saito H, et al. Short-term efficacy and safety of PreserFlo MicroShunt in Japanese patients with medically treated primary open-angle glaucoma. Jpn J Ophthalmol. 2025;69:287\u201395.","journal-title":"Jpn J Ophthalmol"},{"key":"1368_CR8","doi-asserted-by":"publisher","first-page":"e45079","DOI":"10.1371\/journal.pone.0045079","volume":"7","author":"JW Cheng","year":"2012","unstructured":"Cheng JW, Cheng SW, Gao LD, Lu GC, Wei RL. Intraocular pressure-lowering effects of commonly used fixed-combination drugs with timolol: a systematic review and meta-analysis. PLoS ONE. 2012;7:e45079.","journal-title":"PLoS ONE"},{"key":"1368_CR9","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.ogla.2022.10.002","volume":"6","author":"A Fujita","year":"2023","unstructured":"Fujita A, Hashimoto Y, Matsui H, Yasunaga H, Aihara M. Recent trends in treatment and associated costs of primary angle-closure glaucoma: a retrospective cohort study. Ophthalmol Glaucoma. 2023;6:308\u201315.","journal-title":"Ophthalmol Glaucoma"},{"key":"1368_CR10","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/S0002-9394(14)70172-2","volume":"123","author":"PA Netland","year":"1997","unstructured":"Netland PA, Weiss HS, Stewart WC, Cohen JS, Nussbaum LL, Night Study Group. Cardiovascular effects of topical carteolol hydrochloride and timolol maleate in patients with ocular hypertension and primary open-angle glaucoma. Am J Ophthalmol. 1997;123:465\u201377.","journal-title":"Am J Ophthalmol"},{"key":"1368_CR11","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/S0002-9394(14)70865-7","volume":"124","author":"WC Stewart","year":"1997","unstructured":"Stewart WC, Cohen JS, Netland PA, Weiss H, Nussbaum LL, Nocturnal Investigation of Glaucoma Hemodynamics Trial Study Group. Efficacy of carteolol hydrochloride 1% vs timolol maleate 0.5% in patients with increased intraocular pressure. Am J Ophthalmol. 1997;124:498\u2013505.","journal-title":"Am J Ophthalmol"},{"key":"1368_CR12","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1007\/s10384-023-01020-8","volume":"67","author":"K Kashiwagi","year":"2023","unstructured":"Kashiwagi K, Ouchi K, Shibasaki Y, Suginaka M. Persistence of the carteolol hydrochloride\/latanoprost fixed-combination ophthalmic solution, compared with the other \u03b2-blocker\/prostanoid FP receptor agonist fixed-combination ophthalmic solutions. Jpn J Ophthalmol. 2023;67:658\u201367.","journal-title":"Jpn J Ophthalmol"},{"key":"1368_CR13","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1016\/S0140-6736(14)62111-5","volume":"385","author":"DF Garway-Heath","year":"2015","unstructured":"Garway-Heath DF, Crabb DP, Bunce C, Lascaratos G, Amalfitano F, Anand N, et al. Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trial. Lancet. 2015;385:1295\u2013304.","journal-title":"Lancet"},{"key":"1368_CR14","first-page":"2566","volume":"41","author":"N Orzalesi","year":"2000","unstructured":"Orzalesi N, Rossetti L, Invernizzi T, Bottoli A, Autelitano A. Effect of timolol, latanoprost, and dorzolamide on circadian IOP in glaucoma or ocular hypertension. Invest Ophthalmol Vis Sci. 2000;41:2566\u201373.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1368_CR15","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.ophtha.2019.10.022","volume":"127","author":"PA Newman-Casey","year":"2020","unstructured":"Newman-Casey PA, Niziol LM, Gillespie BW, Janz NK, Lichter PR, Musch DC. The association between medication adherence and visual field progression in the Collaborative Initial Glaucoma Treatment Study. Ophthalmology. 2020;127:477\u201383.","journal-title":"Ophthalmology"}],"container-title":["Japanese Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10384-026-01368-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10384-026-01368-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10384-026-01368-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T18:01:53Z","timestamp":1790445713000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10384-026-01368-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,11]]},"references-count":15,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["1368"],"URL":"https:\/\/doi.org\/10.1007\/s10384-026-01368-7","relation":{},"ISSN":["0021-5155","1613-2246"],"issn-type":[{"value":"0021-5155","type":"print"},{"value":"1613-2246","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,11]]},"assertion":[{"value":"27 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"K. Inoue, Grants or contracts (Santen, A2 Healthcare, Teijin, SEED, ONO, GSK, Senju), Lecture fee (Senju, Otsuka, Kowa, Santen, ROHTO, Chugai, Viatris); M. Shiokawa, None; S. Kunimatsu-Sanuki, Lecture fee (Santen, Novartis, Senju, Viatris, Kowa, ROHTO); G. Tomita, Grants (Senju, Viatris, Nitto Medic); K. Ishida, Lecture fee (Alcon, Senju, Otsuka, Kowa, Nitto Medic, Glaukos, JFC Sales Plan, Santen).","order":1,"name":"Ethics","label":"Conflicts of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}